Moisture effect Study
- Registration Number
- CTRI/2020/09/028151
- Lead Sponsor
- Azafran Innovacion ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 38
1)Babies in the age group of 0 (including new born full term babies Day 1) to 36 months (inclusive of both genders) at the time of consent.
2)APGAR score >7 at 1 and 5 minutes with no resuscitation required at birth for babies of 0-7 days [Refer Appendix V for APGAR scoring].
3)Babiesâ?? general in good health as determined from a recent medical history
4)Babiesâ?? mother/legal representative, preferably mother willing to give a voluntary written parental informed consent and agree to come for regular follow up.
5)Babiesâ?? mother/legal representative, preferably mother willing to abide by and comply with the study protocol.
6)Babies should not participate in any other clinical study during participation in the current study
1)Babiesâ?? mother/ legal caretaker not willing to stop the use of other baby body milk /lotion / cream or any other baby face/body moisturizing product during the study period.
2)Chronic illness which may influence the cutaneous state.
3)Babies on any systemic medication.
4)Babies participating in a similar clinical study, currently or during the previous 30 days.
5)Any baby, in the Investigators opinion not considered suitable for enrollment.
6)A known history or present condition of allergic response to any other concern that may require medical attention.
7)Babies with medical history (past | present) of significant dermatological diseases or conditions, such as atopy, psoriasis, vitiligo or other conditions known to alter skin appearance or physiologic response (e.g. porphyria) chronic urticaria, or sunburn, rashes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method